Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 505 of 6351
-
Could a daily probiotic prevent iron deficiency in pregnancy?
Prevention Recruiting nowMaternal iron deficiency (ID) and iron deficiency anemia (IDA) is associated with maternal and infant mortality, spontaneous preterm birth, maternal postpartum hemorrhage, and neurocognitive defects in the neonate. Therefore, preventing maternal IDA in at-risk women is critical. …
Phase 2 • Sponsor: University of Illinois at Chicago • Aim: Prevention
Last updated Jun 27, 2026 12:28 UTC
-
Can plasma help heal the brain after injury?
Disease control Recruiting nowThe goal of this clinical trial is to learn about treatment with fresh frozen plasma (FFP) in individuals with moderate to severe traumatic brain injury. The two main question\[s\]it aims to answer are: * Is the FFP treatment safe? * Does the FFP treatment impact the 24-hour, 3-…
Phase 2/3 • Sponsor: Northwestern University • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
New program aims to cut cervical cancer risk in vulnerable women
Prevention Recruiting nowCervical cancer (CC) remains one of the most common malignancies among women in India, with nearly 100,000 women diagnosed annually and over 60,000 preventable deaths annually. With high-risk human papillomavirus (HR-HPV) as the causative agent for CC, one risk factor that places…
Sponsor: University of California, Irvine • Aim: Prevention
Last updated Aug 02, 2026 00:00 UTC
-
New hope for tough colon cancer: combo therapy targets BRAF mutation
Disease control Not yet recruitingThis is an open-label, single-arm, single-center phase II clinical study, aiming to investigate the safety and efficacy of Aipalolitovorelizumab (QL1706) combined with bevacizumab plus standard chemotherapy regimen as first-line treatment for patients with MSS/pMMR metastatic col…
Phase 2 • Sponsor: Yanqiao Zhang • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
New device could save lives by stopping severe bleeding in trauma patients
Disease control Not yet recruitingThis study seeks to evaluate the feasibility of a Abdominal Aortic Balloon Occlusion of the Aorta (AAJT-S) in exanguinating trauma patients with non-compressible truncal haemorrhage in the emergency room and the pre-hospital setting.
Sponsor: Medical University of Graz • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
New combo therapy targets hard-to-treat pancreatic cancer liver spread
Disease control Not yet recruitingTo evaluate the efficacy of arterial infusion chemotherapy and embolization combined with iparplidutol-volerilis (QL1706) as first-line treatment for pancreatic cancer liver metastases based on progression-free survival (PFS).
Phase 2 • Sponsor: Shandong Provincial Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
Bladder cancer patients may get new hope from virus treatment
Disease control Not yet recruitingThis is a prospective, open label, single center clinical study on the use of recombinant human adenovirus type 5 injection for bladder instillation therapy in high-risk non muscle invasive bladder urothelial carcinoma patients. The study was administered in a dose escalation man…
Phase 2 • Sponsor: RenJi Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
New hope for lymphoma patients: experimental drug combo enters final trial phase
Disease control Not yet recruitingThis study is a randomized, controlled, double-blind, multicenter, phase III clinical study to evaluate the efficacy of IMM0306 (Amulirafusp Alfa)in combination with lenalidomide versus placebo in combination with lenalidomide in patients with Relapsed/Refractory Follicular lymph…
Phase 3 • Sponsor: ImmuneOnco Biopharmaceuticals (Shanghai) Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New combo therapy aims to tackle tough sarcomas
Disease control Not yet recruitingThe primary objective of this clinical trial is to evaluate the efficacy and safety of spatially fractionated radiotherapy combined with the PraG strategy in the treatment of soft tissue sarcoma (STS). The main questions it aims to answer are: 1. Can spatially fractionated radio…
Phase 2 • Sponsor: First Affiliated Hospital of Guangxi Medical University • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
New hope for rare melanomas? drug combo enters phase 2 trial
Disease control Not yet recruitingThis is a prospective, single-arm, multicenter, phase II clinical trial designed to evaluate the efficacy and safety of iparomlimab and tuvoraleimab, in combination with bevacizumab, albumin-bound paclitaxel, and carboplatin as first- or second-line treatment in patients with acr…
Phase 2 • Sponsor: Fudan University • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
Can ketamine and mindfulness break the grip of opioid addiction?
Disease control Not yet recruitingThe goal of this clinical trial is to examine the usefulness of Mindfulness-Oriented Recovery Enhancement combined with Ketamine-Assisted Psychotherapy (KetaMORE) for individuals with opioid use disorder who are receiving medication treatment. The main question it aims to answer …
Phase 2 • Sponsor: University of California, San Diego • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
New hope for tough breast cancer: targeted pill after chemo shows promise in large trial
Disease control Not yet recruitingThis study enrolled patients with early-stage triple-negative breast cancer who had undergone radical surgery. The postoperative pathology met the TNM staging criteria of pT1c-3N0-3M0, and immunohistochemistry (IHC) results confirmed ER-negative status (IHC showed \<1% of tumor c…
Phase 3 • Sponsor: Fudan University • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
AI reads CT scans to guide colon cancer treatment
Diagnosis Not yet recruitingThis study aims to improve the classification of colon tumors using deep learning models trained on CT scans, specifically to distinguish between T1-T2 vs. T3-T4 stages and N- vs. N+ lymph node involvement. This classification is critical to guide preoperative treatment such as c…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Diagnosis
Last updated Jun 27, 2026 09:05 UTC
-
Fasting diet and exercise may boost chemo in aggressive breast cancer
Disease control Recruiting nowLESLIE is a multicentric randomized controlled trial in patients with triple negative breast cancer receiving neoadjuvant chemo/immunotherapy (NAT). This trial investigates the hypothesis that adding a cyclic fasting-mimicking diet combined with exercise during the NAT improves t…
Phase 2 • Sponsor: Universitaire Ziekenhuizen KU Leuven • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
Radiation and immunotherapy combo targets untreatable liver tumors
Disease control Recruiting nowThis clinical trial was designed to evaluate the safety and efficacy of Y90-SIRT combined with nivolumab, ipilimumab, and lenvatinib in patients with unresectable HCC. In addition to assessing short-term efficacy endpoints, such as ORR and PFS, this trial places particular emphas…
Phase 1/2 • Sponsor: West China Hospital • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
New hope for drug-resistant lung cancer: combo therapy enters trial
Disease control Recruiting nowEfficacy and Safety of Sacituzumab Tirumotecan Combined with Furmonertinib in Patients with Locally Advanced or Metastatic Non-squamous Non-Small Cell Lung Cancer Who Have Progressed After EGFR-TKI and Platinum-Based Chemotherapy.
Phase 2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New test could prevent unnecessary surgery for common skin precancers
Diagnosis OngoingActinic keratoses are precancerous skin lesions that are the most common among all cancers and precancerous conditions in fair-skinned populations. The distinctive feature of these actinic keratoses is that some progress into skin cancers known as cutaneous carcinomas, while othe…
Sponsor: Centre Hospitalier Régional Metz-Thionville • Aim: Diagnosis
Last updated Jun 27, 2026 13:00 UTC
-
Could a home exercise program prime the body against breast cancer?
Disease control Recruiting nowPhActHealth is a multicenter randomized controlled trial enrolling women with newly diagnosed luminal B or triple-negative breast cancer (BC) who are candidates for neoadjuvant therapy. The study aims to investigate the effects of a preoperative, unsupervised exercise training pr…
Sponsor: University of Milan • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
Sleep disorder may hold the key to spotting Parkinson's years earlier
Knowledge-focused Recruiting nowComprehensive characterization of early-stage Parkinson's disease in patients with REM sleep behavior disorder Parkinson's disease (PD) is the fastest-growing neurodegenerative disorder worldwide, significantly affecting quality of life and causing substantial social and economi…
Sponsor: Danish Research Centre for Magnetic Resonance • Aim: Knowledge-focused
Last updated Aug 29, 2026 00:00 UTC
-
Weight loss through friendship: a new trial tests spreading healthy habits via social networks
Prevention Recruiting nowAim 1. Conduct a 6-month (24-session) RCT comparing MedDiet-WL to MedDiet-SN among 268 older adults with obesity (50-79 years, BMI = 30-50 kg/m²). We hypothesize that 1) Participants in MedDiet-SN will show improvements in bodyweight/BMI and body fat compared to MedDiet-WL at pos…
Sponsor: University of Illinois at Chicago • Aim: Prevention
Last updated Sep 03, 2026 00:00 UTC